Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer

Ustaalioglu B. B. O., Bilici A., Barisik N. O., ALİUSTAOĞLU M., Vardar F. A., Yilmaz B. E., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, no.12, pp.911-922, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 12
  • Publication Date: 2012
  • Doi Number: 10.1007/s12094-012-0880-5
  • Journal Name: CLINICAL & TRANSLATIONAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.911-922
  • Kütahya Health Sciences University Affiliated: No

Abstract

Several biomarkers have been previously studied for breast cancer to define risk of recurrence and metastasis. Phosphatase of regenerating liver-3 (PRL-3) is one of them. High PRL-3 expression has been found to be correlated with axillary lymph node metastasis and survival in breast cancer. Herein, we evaluated the prognostic significance of PRL-3 expression and the relationship between PRL-3 and other clinicopathological factors.